Chronic immune checkpoint inhibitor (ICI) pneumonitis in patients (pts) with non-small cell lung cancer (NSCLC).

被引：1
|
作者：
Stuart, Jessica
Ricciuti, Biagio
Alessi, Joao Victor Machado
Nishino, Mizuki
Awad, Mark M.
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.9103
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9103
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Association of human leukocyte antigen (HLA) status with immune checkpoint inhibitor (ICI) pneumonitis in patients with non-small cell lung cancer (NSCLC)
    Li, Molly S. C.
    Cheung, Alvin H. K.
    Mui, Zeta
    Chow, Chit
    Lau, Yat Ming
    Wong, Kit Yee
    Kang, Wei
    To, Ka Fai
    Mok, Tony S. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Prognostic factors in non-small cell lung cancer (NSCLC) patients (pts) with brain metastases (BM) treated with immune checkpoint inhibitors (ICI)
    Hendriks, L.
    Henon, C.
    Auclin, E.
    Mezquita, L.
    Ferrara, R.
    Valette, C. Audigier
    Mazieres, J.
    Lefebvre, C.
    Le Moulec, S.
    Duchemann, B.
    Le Pechoux, C.
    Botticella, A.
    Ammari, S.
    Gazzah, A.
    Caramella, C.
    Adam, J.
    Planchard, D.
    De Ruysscher, D.
    Dingemans, A-M. C.
    Besse, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine, 2020, 17 (03) : 599 - 611
  • [4] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Zhai, Xiaoyang
    Zhang, Jian
    Tian, Yaru
    Li, Ji
    Jing, Wang
    Guo, Hongbo
    Zhu, Hui
    CANCER BIOLOGY & MEDICINE, 2020, 17 (03) : 599 - 611
  • [5] The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
    Xiaoyang Zhai
    Jian Zhang
    Yaru Tian
    Ji Li
    Wang Jing
    Hongbo Guo
    Hui Zhu
    Cancer Biology & Medicine , 2020, (03) : 599 - 611
  • [6] Response to neoadjuvant immune checkpoint inhibitor (ICI)-based therapy in oncogenedriven resectable non-small cell lung cancer (NSCLC)
    Rosner, Samuel
    Sivapalan, Lavanya
    Zahurak, Marianna
    Thummalapalli, Rohit
    Rayes, Roni
    Connor, Sydney
    Sanber, Khaled
    Reuss, Joshua E.
    Pereira, Gavin
    Smith, Kellie Nicole
    Anagnostou, Valsamo
    Broderick, Stephen
    Jones, David Randolph
    Brahmer, Julie R.
    Marrone, Kristen A.
    Spicer, Jonathan
    Chaft, Jamie E.
    Forde, Patrick M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [7] CheckpointPx: A predictive radiology AI model of immune checkpoint inhibitor (ICI) benefit in non-small cell lung cancer (NSCLC)
    Lee, Seyoung
    Hiremath, Amogh
    Lee, Jeeyeon
    Kim, Haseok
    Zhang, Kai
    Lee, Salie
    Yadav, Monica
    Chung, Liam Il Young
    Kim, Hye Sung
    Djunadi, Trie Arni
    Kim, Yuchan
    Hong, Ilene
    Kang, Grace
    Cho, Amy
    Velichko, Yury
    Gupta, Amit
    Velcheti, Vamsidhar
    Madabhushi, Anant
    Braman, Nathaniel
    Chae, Young Kwang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Immunotherapy Fits Everyone? Prognostic Markers for Immune-checkpoint-Inhibitor (ICI) in Non-small Cell Lung Cancer (NSCLC)
    Baptista De Almeida, S.
    Caleca, T.
    Silva, M.
    Honorio, M.
    Chaves, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1136 - S1136
  • [9] Immune checkpoint inhibitor-related pneumonitis in non-small cell lung cancer: A review
    Hao, Yuxuan
    Zhang, Xiaoye
    Yu, Li
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [10] Prediction of immune checkpoint inhibitor (ICI) response in non-small cell lung cancer (NSCLC) patients using a microbiome-based biomarker
    Robinson, Irina
    Hochmair, Maximilian Johannes
    Jansen, Christian
    Pacifico, Catia
    Sladek, Barbara
    Knabl, Alexander
    Gasche, Nikolaus
    Absenger, Gudrun
    Pichler, Martin
    Valipour, Arschang
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (19-20) : 742 - 742
12345